Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01705691 | Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer | completed | Phase 2 | 50 | NSABP Foundation IncNETWORK | 2 | Oct 6, 2021 | clinicaltrials |
| NCT00206427 | Neoadjuvant GW572016 to Treat Breast Cancer(GW) | completed | Phase 2 | 49 | Baylor Breast Care CenterOTHER | 1 | Sep 29, 2021 | clinicaltrials |
| NCT01535040 | Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | completed | Phase 2 | 130 | Wake Forest University Health SciencesOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT02742051 | A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer | completed | Phase 2 | 40 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Sep 23, 2021 | clinicaltrials |
| NCT05053841 | Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women | completed | Phase 2 | 45 | Tanta UniversityOTHER | 0 | Sep 23, 2021 | clinicaltrials |
| NCT01097642 | Neo-Adjuvant Study in Triple Negative Breast Cancer Patients(ICE) | completed | Phase 2 | 40 | The Methodist Hospital Research InstituteOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | completed | Phase 2 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT02073487 | Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel(TEAL) | completed | Phase 2 | 32 | The Methodist Hospital Research InstituteOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT02988986 | TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer(ANETT) | completed | Phase 2 | 28 | The Methodist Hospital Research InstituteOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT03931928 | Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients(TAMENDOX) | completed | Phase 2 | 356 | Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)OTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT01847001 | Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy | completed | Phase 2 | 10 | Columbia UniversityOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03139851 | Evaluation of Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated With Metronomic Cyclophosphamide(CHEMOIMMUNE) | completed | Phase 2 | 36 | Centre Leon BerardOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT03716583 | Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer(MELADERM) | completed | Phase 2 | 48 | Dennis Bregner ZetnerOTHER | 1 | Sep 10, 2021 | clinicaltrials |
| NCT00041652 | Safety Study of hMN14 to Treat Either Colorectal or Breast Cancer | completed | Phase 1 / Phase 2 | 30 | Gilead SciencesINDUSTRY | 1 | Aug 19, 2021 | clinicaltrials |
| NCT04059809 | Photobiomodulation for Breast Cancer Radiodermatitis | completed | Phase 2 / Phase 3 | 48 | AC Camargo Cancer CenterOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT01631552 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | completed | Phase 1 / Phase 2 | 515 | Gilead SciencesINDUSTRY | 1 | Aug 12, 2021 | clinicaltrials |
| NCT02807844 | Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies | completed | Phase 1 / Phase 2 | 141 | Novartis PharmaceuticalsINDUSTRY | 11 | Aug 11, 2021 | clinicaltrials |
| NCT00574678 | Analyzing the Composition of Tears to Identify Cancer(ACT) | completed | Phase 1 / Phase 2 | 150 | University of ArkansasOTHER | 1 | Aug 5, 2021 | clinicaltrials |
| NCT01931163 | NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer(NECTAR) | completed | Phase 2 | 24 | Jenny C. Chang, MDOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT02593227 | Folate Receptor Alpha Peptide Vaccine With GM-CSF in Patients With Triple Negative Breast Cancer | completed | Phase 2 | 80 | Marker Therapeutics, Inc.INDUSTRY | 1 | Jul 19, 2021 | clinicaltrials |
| NCT03092934 | A Study of AK-01 (LY3295668) in Solid Tumors | completed | Phase 1 / Phase 2 | 13 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 2, 2021 | clinicaltrials |
| NCT01023477 | Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial) | completed | Phase 1 / Phase 2 | 12 | Inova Health Care ServicesOTHER | 1 | Jun 29, 2021 | clinicaltrials |
| NCT02718144 | Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer | completed | Phase 1 / Phase 2 | 12 | Pantarhei Oncology B.V.OTHER | 1 | Jun 18, 2021 | clinicaltrials |
| NCT03113825 | Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery | completed | Phase 2 | 92 | Avelas Biosciences, Inc.INDUSTRY | 1 | Jun 11, 2021 | clinicaltrials |
| NCT00629616 | Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer(NIMFEA) | completed | Phase 2 | 116 | UNICANCEROTHER | 1 | Jun 9, 2021 | clinicaltrials |
| NCT02505048 | A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic Signature(RUBY) | completed | Phase 2 | 41 | UNICANCEROTHER | 1 | Jun 8, 2021 | clinicaltrials |
| NCT00208273 | Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer | completed | Phase 2 | 150 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT00580333 | Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer | completed | Phase 2 | 51 | Massachusetts General HospitalOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT00971945 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer | completed | Phase 2 | 6 | Bristol-Myers SquibbINDUSTRY | 1 | May 25, 2021 | clinicaltrials |
| NCT03411161 | S 81694 Plus Paclitaxel in Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 22 | Institut de Recherches Internationales ServierOTHER | 4 | May 25, 2021 | clinicaltrials |
| NCT02260531 | Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases | completed | Phase 2 | 36 | Dana-Farber Cancer InstituteOTHER | 1 | May 20, 2021 | clinicaltrials |
| NCT02909751 | Tocotrienol in Combination With Neoadjuvant Chemotherapy for Women With Breast Cancer(NeoToc) | completed | Phase 2 | 80 | Vejle HospitalOTHER | 1 | May 20, 2021 | clinicaltrials |
| NCT00546156 | Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer | completed | Phase 2 | 104 | Ian E. Krop, MD, PhDOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT02186015 | Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)(SAFE-D) | completed | Phase 2 | 43 | Loyola UniversityOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT02953860 | Fulvestrant Plus Enzalutamide in ER+/Her2- Advanced Breast Cancer | completed | Phase 2 | 32 | University of Colorado, DenverOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT00256217 | Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women | completed | Phase 2 | 42 | Rita Sanghvi, MehtaOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT02413320 | Neoadjuvant Study of Two Platinum Regimens in Triple Negative Breast Cancer(NeoSTOP) | completed | Phase 2 | 101 | Priyanka SharmaOTHER | 1 | May 10, 2021 | clinicaltrials |
| NCT02732119 | Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.(TRINITI-1) | completed | Phase 1 / Phase 2 | 104 | Novartis PharmaceuticalsINDUSTRY | 1 | May 5, 2021 | clinicaltrials |
| NCT00723125 | Carboplatin, Abraxane, Avastin as Neoadjuvant Therapy for Her2-Negative Breast Cancer | completed | Phase 2 | 60 | William Sikov MDOTHER | 1 | Apr 29, 2021 | clinicaltrials |
| NCT02041429 | Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca | completed | Phase 1 / Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT01310231 | A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer | completed | Phase 2 | 40 | Ozmosis Research Inc.INDUSTRY | 1 | Apr 14, 2021 | clinicaltrials |
| NCT00365417 | Therapy With Bevacizumab (BEV), Doxorubicin, and Cyclophosphamide Followed by BEV, Docetaxel, and Capecitabine Before Surgery Followed by BEV Alone After Surgery for Women With Locally Advanced Breast Cancer | completed | Phase 2 | 45 | NSABP Foundation IncNETWORK | 1 | Apr 13, 2021 | clinicaltrials |
| NCT03289819 | Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC(NIB) | completed | Phase 2 | 53 | Institut fuer FrauengesundheitOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT01009918 | Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab | completed | Phase 2 | 468 | University of South FloridaOTHER | 1 | Mar 30, 2021 | clinicaltrials |
| NCT01835236 | Trastuzumab & Pertuzumab Followed by T-DM1 in MBC | completed | Phase 2 | 208 | Swiss Cancer InstituteOTHER | 4 | Mar 30, 2021 | clinicaltrials |
| NCT01231659 | Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | completed | Phase 2 | 72 | Novartis PharmaceuticalsINDUSTRY | 1 | Mar 26, 2021 | clinicaltrials |
| NCT01967823 | T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03248427 | Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.(CORALLEEN) | completed | Phase 2 | 106 | SOLTI Breast Cancer Research GroupOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT01037790 | Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer | completed | Phase 2 | 304 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 11, 2021 | clinicaltrials |
Data updated 24 days agoSource updated Oct 6, 2021source: clinicaltrials